12 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
27 Oct 23
Regulation FD Disclosure
4:19pm
complications include hyperacute graft-versus-host-disease (GVHD), acute GVHD, chronic GVHD, hepatic veno-occlusive disease (VOD) after reduced intensity
10-K
ip11qizzaks84ak
23 Mar 15
Annual report
12:00am
424B4
ndxocjekdn2nd31q
6 Nov 14
Prospectus supplement with pricing info
12:00am
DRS
EX-10.9
m2h0c
4 Aug 14
Draft registration statement
12:00am
- Prev
- 1
- Next